Skip to main content

Day: June 26, 2023

Brandt Expands Commitment to North Island with Acquisition of Wairarapa Machinery Services

Brandt Locations in New Zealand, June 2023 A map showing all of Brandt’s operating locations as of June, 2023PUKEKOHE, New Zealand, June 26, 2023 (GLOBE NEWSWIRE) — The Brandt Group of Companies is pleased to announce that they have reached an agreement to acquire the assets of Wairarapa Machinery Services Ltd. Wairarapa Machinery is a familiar face in the Greater Wellington Region, serving the local community with a range of premium new and used farm and lawncare equipment since 1983. The announcement unites New Zealand’s North Island under one dealer brand and will continue with business as usual, featuring the same team that customers have come to know and trust over the past 40 years. “Combining all of the Deere dealerships on the North Island under one banner is going to result in more comprehensive support for New...

Continue reading

TCM Group A/S: TCM Group A/S Announces Completion of Directed Issue of 1,221,419 New Shares

COMPANY ANNOUNCEMENT                                                                                                                     No. 171/2023 Tvis, 26 June 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL. TCM Group A/S Announces Completion of Directed Issue of 1,221,419 New Shares On 26 June 2023, TCM Group A/S (“TCM” or the “Company”) announced its intention to raise new capital through an accelerated bookbuilding process. The offering (the “Offering”) of new shares (the “New Shares”) in TCM has now been successfully completed. Reference is made to company announcement no. 170 of 26...

Continue reading

O-I GLASS ANNOUNCES SECOND QUARTER 2023 EARNINGS CONFERENCE CALL AND WEBCAST

PERRYSBURG, Ohio, June 26, 2023 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) has scheduled its second quarter 2023 conference call and webcast for Wednesday, August 2, 2023, at 8 a.m. EDT. The Company’s news release for the second quarter 2023 earnings will be issued after the market closes on Tuesday, August 1. What:         O-I Conference Call and WebcastEarnings presentation materials will also be posted on the O-I website, www.o-i.com/investors, when the earnings news release is issued. When:         Wednesday, August 2, 2023, at 8 a.m. EDT Where:         https://events.q4inc.com/attendee/505141931 or at www.o-i.com/investors, Events and Presentations page The webcast will be archived at www.o-i.com/investors until August 2024. About O-I    At O-I Glass, Inc. (NYSE: OI), we love glass and we’re proud to be one of the leading...

Continue reading

ARMOUR Residential REIT, Inc. Announces Guidance For July 2023 Dividend Rate Per Common Share

VERO BEACH, Florida, June 26, 2023 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the July 2023 cash dividend for the Company’s Common Stock of $0.08 per Common share. July 2023 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateJuly 2023   $0.08   July 17, 2023   July 28, 2023Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined at...

Continue reading

Dundee Corporation Announces Acquisition of Units of Bulgold Inc.

TORONTO, June 26, 2023 (GLOBE NEWSWIRE) — In accordance with regulatory requirements, Dundee Corporation (TSX: DC.A) (“Dundee”) announces that its wholly owned subsidiary, Dundee Resources Limited, has acquired 1,666,667 units (the “Units”) of Bulgold Inc. (TSXV – ZLTO) (the “Issuer”) at the price of C$0.30 per Unit for aggregate consideration of C$500,000. Each Unit is comprised of one common share and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Issuer at an exercise price of C$0.40 per share until December 23, 2024. Immediately prior to the acquisition of securities described in this news release, Dundee and its affiliates owned 1,587,300 common shares of the Issuer representing an approximate 7.85%...

Continue reading

VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals

BASEL, Switzerland, June 26, 2023 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a global clinical-stage biopharmaceutical company pioneering novel, transformational treatments for severe rare gastrointestinal conditions, announced that today’s extraordinary general meeting approved each of the proposals of the Board of Directors, which satisfied one of the pending conditions to consummating the tender offer by Ironwood Pharmaceuticals, Inc. (“Ironwood”) to acquire all of VectivBio’s outstanding registered ordinary shares for $17.00 per share in cash (subject to deduction for any applicable withholding taxes). Consummation of the tender offer remains subject to the tender of more than 80% of the total number of VectivBio’s outstanding registered ordinary shares and the other conditions described...

Continue reading

Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange

HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) — Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced today it has been selected to exhibit the Aurix® System, the first platelet rich plasma (PRP) device indicated for chronic diabetic wounds, at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine, Texas. The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their product or service to supply chain and clinical leaders from Vizient’s member hospitals and subject matter experts who serve on their...

Continue reading

*Amended* Form 8.3 – Horizon Therapeutics plc

Ap27 FORM 8.3 IRISH TAKEOVER PANEL AMENDED DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION(a)   Full name of discloser P. Schoenfeld Asset Management LP(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree Horizon Therapeutics plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)  (e)   Date position held/dealing...

Continue reading

Nokia Corporation: Repurchase of own shares on 26.06.2023

Nokia CorporationStock Exchange Release26 June 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 26.06.2023 Espoo, Finland – On 26 June 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 332,138 3.73CEUX 26,617 3.74AQEU 2,198 3.73TQEX 14,047 3.74Total 375,000 3.73* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Continue reading

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2023 ENDED MARCH 31, 2023

MINNEAPOLIS, MN, US, June 26, 2023 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, will report financial results for the year ending March 31, 2023, on Thursday, June 29, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo’s Investor Relations website at: https://audience.mysequire.com/webinar-view?webinar_id=19521825-9284-4391-bfe3-8ed5b4ec0774 A replay of the webcast will be available through the same link following the conference call. Participants can also...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.